Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end – Fierce Pharma

  1. Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end  Fierce Pharma
  2. Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow  CNBC
  3. Moderna will lay off 10% of employees, Massachusetts-based company announces  CBS News
  4. Vaccine maker Moderna cuts hundreds of jobs; CEO says ‘every effort’ made to avoid layoffs  The Business Journals
  5. Moderna announces layoffs, and Alnylam’s heart drug sees quick uptake  statnews.com

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *